BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24918192)

  • 1. Is there a role for generic antiretroviral drugs in the United States?
    Wormser GP; Lappas T
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):897-9. PubMed ID: 24918192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.
    Venkatesh KK; Mayer KH; Carpenter CC
    Health Aff (Millwood); 2012 Jul; 31(7):1429-38. PubMed ID: 22778332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of generic HIV drugs in Rhode Island.
    Lee JY; Reece R; Montague B; Rana A; Alexander-Scott N; Flanigan T
    R I Med J (2013); 2013 Sep; 96(9):30-3. PubMed ID: 24015398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic antiretroviral drugs are a credible and cheaper alternative to brands.
    BMJ; 2013 Jan; 346():f250. PubMed ID: 23325870
    [No Abstract]   [Full Text] [Related]  

  • 5. Generic HIV drugs will widen US treatment net.
    Maxmen A
    Nature; 2012 Aug; 488(7411):267. PubMed ID: 22895314
    [No Abstract]   [Full Text] [Related]  

  • 6. Global AIDS trial denied patients as US balks at generic drug use.
    Check E
    Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219
    [No Abstract]   [Full Text] [Related]  

  • 7. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
    Tucker T; Yeats J
    S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
    [No Abstract]   [Full Text] [Related]  

  • 8. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 9. Access to essential medications for HIV/AIDS in South Africa.
    Andrews S
    S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
    [No Abstract]   [Full Text] [Related]  

  • 10. Generic drugs battle moves from South Africa to Kenya.
    Siringi S
    Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
    [No Abstract]   [Full Text] [Related]  

  • 11. Kenya says yes to generic ARVs but fails to win Global Fund cash.
    Njoroge J
    Bull World Health Organ; 2002; 80(7):608. PubMed ID: 12163933
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 13. Indian company seeks US approval for generic AIDS drugs.
    Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
    [No Abstract]   [Full Text] [Related]  

  • 14. 100th HIV/AIDS antiretroviral drug approved by PEPFAR.
    AIDS Patient Care STDS; 2009 Nov; 23(11):988-9. PubMed ID: 19938372
    [No Abstract]   [Full Text] [Related]  

  • 15. Policy shift. Bush's AIDS plan includes condom distribution, generic drugs.
    AIDS Policy Law; 2003 Feb; 18(3):5. PubMed ID: 12635615
    [No Abstract]   [Full Text] [Related]  

  • 16. World Trade Organization still threatens supply of affordable AIDS drugs.
    Hagmann M
    Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
    [No Abstract]   [Full Text] [Related]  

  • 17. India: New patent law may restrict access to HIV/AIDS treatments.
    Cruess G
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries.
    Waning B; Diedrichsen E; Moon S
    J Int AIDS Soc; 2010 Sep; 13():35. PubMed ID: 20840741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The patent legislation in India fails the HIV/AIDS work].
    Holen Ø
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
    [No Abstract]   [Full Text] [Related]  

  • 20. [HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():62-3. PubMed ID: 25026863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.